- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
7th grade Avg
|
- 10-K Annual report
- 10.6 Outside Director Stock Option Agree.
- 10.14 Second Amendment to Credit Agreement
- 10.15 Third Amendment to Credit Agreement
- 10.22 Letter to DR. Michael P. Silvon
- 13 Exhibit 13 - Annual Report
- 21.1 Exhibit 21.1
- 23.1 Consent
- 31.1 Exhibit 31.1 - Certifications
- 31.2 Exhibit 31.2
- 32 Exhibit 32
- 99 Exhibit 99 - Risk Factors
Exhibit 32
I, Peter T. Kissinger, the Chairman of the Board; President; and Chief Executive Officer of Bioanalytical Systems, Inc., certify that (i) the Annual Report on Form 10-K for the year ended September 30, 2003, (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Bioanalytical Systems, Inc. as of the dates and for the periods set forth therein.
/s/ Peter T. Kissinger Peter T. Kissinger Chairman of the Board President and Chief Executive Officer January 13, 2004 |
I, Michael P. Silvon, the interim Chief Financial Officer and Vice President Planning and Development of Bioanalytical Systems, Inc., certify that (i) the Annual Report on Form 10-K for the year ended September 30, 2003, (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Bioanalytical Systems, Inc. as of the dates and for the periods set forth therein.
/s/ Michael P. Silvon Michael P. Silvon Chief Financial Officer (Interim) Vice President, Planning & Development January 13, 2004 |